These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 1531749)

  • 1. Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.
    Layet S; Girma JP; Obert B; Peynaud-Debayle E; Bihoreau N; Meyer D
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):129-37. PubMed ID: 1531749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673.
    Christophe O; Obert B; Meyer D; Girma JP
    Blood; 1991 Nov; 78(9):2310-7. PubMed ID: 1834252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factor.
    Takahashi Y; Kalafatis M; Girma JP; Sewerin K; Andersson LO; Meyer D
    Blood; 1987 Nov; 70(5):1679-82. PubMed ID: 3117138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies.
    Girma JP; Kalafatis M; Piétu G; Lavergne JM; Chopek MW; Edgington TS; Meyer D
    Blood; 1986 May; 67(5):1356-66. PubMed ID: 3008890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of a collagen-interactive domain of human von Willebrand factor between amino acid residues Gly 911 and Glu 1,365.
    Kalafatis M; Takahashi Y; Girma JP; Meyer D
    Blood; 1987 Nov; 70(5):1577-83. PubMed ID: 2889486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor.
    Foster PA; Fulcher CA; Marti T; Titani K; Zimmerman TS
    J Biol Chem; 1987 Jun; 262(18):8443-6. PubMed ID: 3110147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topography of the human factor VIII-von Willebrand factor complex.
    Fay PJ; Smudzin TM
    J Biol Chem; 1990 Apr; 265(11):6197-202. PubMed ID: 2108154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor.
    Saenko EL; Scandella D
    J Biol Chem; 1995 Jun; 270(23):13826-33. PubMed ID: 7775440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
    Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP
    Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von willebrand factor.
    Saenko EL; Scandella D
    J Biol Chem; 1997 Jul; 272(29):18007-14. PubMed ID: 9218428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate.
    Andrews RK; Gorman JJ; Booth WJ; Corino GL; Castaldi PA; Berndt MC
    Biochemistry; 1989 Oct; 28(21):8326-36. PubMed ID: 2690940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen.
    Denis C; Baruch D; Kielty CM; Ajzenberg N; Christophe O; Meyer D
    Arterioscler Thromb; 1993 Mar; 13(3):398-406. PubMed ID: 8443144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormality of the N-terminal portion of von Willebrand factor in type IIA and IIC von Willebrand disease.
    Takahashi Y; Kalafatis M; Girma JP; Meyer D
    Thromb Haemost; 1988 Dec; 60(3):498-505. PubMed ID: 3266380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substructure of human von Willebrand factor. Proteolysis by V8 and characterization of two functional domains.
    Fretto LJ; Fowler WE; McCaslin DR; Erickson HP; McKee PA
    J Biol Chem; 1986 Nov; 261(33):15679-89. PubMed ID: 3536910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation.
    Fay PJ; Coumans JV; Walker FJ
    J Biol Chem; 1991 Feb; 266(4):2172-7. PubMed ID: 1846615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirements of von Willebrand factor to protect factor VIII from inactivation by activated protein C.
    Koppelman SJ; van Hoeij M; Vink T; Lankhof H; Schiphorst ME; Damas C; Vlot AJ; Wise R; Bouma BN; Sixma JJ
    Blood; 1996 Mar; 87(6):2292-300. PubMed ID: 8630390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization within the 106 N-terminal amino acids of von Willebrand factor (vWF) of the epitope corresponding to a monoclonal antibody which inhibits vWF binding to factor VIII.
    Piétu G; Ribba AS; Meulien P; Meyer D
    Biochem Biophys Res Commun; 1989 Aug; 163(1):618-26. PubMed ID: 2476129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for the C2 domain of factor VIII in binding to von Willebrand factor.
    Saenko EL; Shima M; Rajalakshmi KJ; Scandella D
    J Biol Chem; 1994 Apr; 269(15):11601-5. PubMed ID: 7512568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries.
    Piétu G; Ribba AS; Chérel G; Siguret V; Obert B; Rouault C; Ginsburg D; Meyer D
    Thromb Haemost; 1994 Jun; 71(6):788-92. PubMed ID: 7974349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic studies on the structure of bovine von Willebrand factor.
    Mascelli MA; Kirby EP
    Biochemistry; 1988 Feb; 27(4):1274-84. PubMed ID: 2452652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.